Skip to main content
SpringerLink
Log in

Eradication by vaccination: the memorial to smallpox could be surrounded by others

  • Chapter
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques

  • 109 Accesses

Abstract

Fifteen years have passed since smallpox was eradicated by vaccination, and we are still far from emulating that success with any other disease. Indeed, little progress has been made with most of the problems that were raised at that time in my previous review for this Journal [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. N. W. Preston: Some unsolved problems with vaccines. Prog. Drug Res. 23: 9–26 (1979).

    Google Scholar 

  2. World Health Organization: International Task Force for disease eradication. Wld. Hlth. Forum 13: 269–270 (1992).

    Google Scholar 

  3. E. Ruiz-Tiben: Only four more years. World Health July-August: 9–10 (1992).

    Google Scholar 

  4. D. Morley: Saving children’s lives by vaccination. Br. Med. J. 299: 1544–1545 (1989).

    Google Scholar 

  5. Centers for Disease Control: Update - International Task Force for dis-ease eradication, 1990 and 1991. MMWR 41: 40–42 (1992).

    Google Scholar 

  6. D. Isaacs, M. Menser: Measles, mumps, rubella, and varicella. Lancet 335: 1384–1387 (1990).

    Google Scholar 

  7. A. Eddleston: Hepatitis. Lancet 335: 1142–1145 (1990).

    Google Scholar 

  8. J. F. Peutherer: Hepadnaviruses. In: D. Greenwood, R.C.B. Slack, J. F. Peutherer, eds. Medical Microbiology, 14th edn. Edinburgh: Churchill-Livingstone, pp. 527–540 (1992).

    Google Scholar 

  9. Centers for Disease Control: Progress towards achieving the national 1990 objectives for immunization. MMWR 37: 613–617 (1988).

    Google Scholar 

  10. Anonymous: Hepatitis A- a vaccine at last. Lancet 339: 1198–1199 (1992).

    Google Scholar 

  11. S. Kingman: Harvard lists top 10 medical advances. Br. Med. J. 306: 738 (1993).

    Article  Google Scholar 

  12. W. H. Bancroft: Hepatitis A vaccine. N. Engl. J. Med. 327: 488–490 (1992).

    Article  Google Scholar 

  13. World Health Organization: Control of viral hepatitis in Europe. Copenhagen: WHO EUR/ICP/OCD 016, pp. 2–4 (1992).

    Google Scholar 

  14. E. R. Moxon, R. Rappuoli: Haemophilus influenzae infections and whooping cough. Lancet 335: 1324–1329 (1990).

    Article  Google Scholar 

  15. R. Booy, E. R. Moxon, J. A. MacFarlane, R. T. Mayon-White, M. P. E. Slack: Efficacy of Haemophilus influenzae type b conjugate vaccine in Oxford region. Lancet 340: 847 (1992).

    Article  Google Scholar 

  16. Department of Health: Immunisation against infectious disease. London: HMSO, pp. 95–99(1992).

    Google Scholar 

  17. J. H. L. Playfair, J. M. Blackwell, H. R. P. Miller: Parasitic diseases. Lancet 335: 1263–1266 (1990).

    Google Scholar 

  18. F. Y. Liew: Vaccination strategies of tropical diseases. Boca Raton, USA: CRC Press (1989).

    Google Scholar 

  19. M. V. Valero, L. R. Amador, C. Galindo, J. Figueroa, M. S. Bello, L. A. Murillo, et al.: Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341: 705–710 (1993).

    Article  Google Scholar 

  20. K. Marsh: Patarroyo’s vaccine. Lancet 341: 729–730 (1993).

    Article  Google Scholar 

  21. M. M. Levine: Enteric infections. Lancet 335: 958–961 (1990).

    Article  Google Scholar 

  22. I. Perez-Schael, M. Blanco, M. Vilar, D. Garcia, L. White, R. Gonzalez, et al.: Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 28: 553–558 (1990).

    Google Scholar 

  23. R.T. Mayon-White: Pneumococcal vaccine. Thorax 43: 345–348 (1988).

    Article  Google Scholar 

  24. F. Shann: Pneumococcus and influenza. Lancet 335: 898–901 (1990).

    Article  Google Scholar 

  25. M. R. Lifely, C. Moreno: Vaccine against meningococcal group B disease. Lancet 1: 214–215 (1986).

    Article  Google Scholar 

  26. M. R. Lifely, C. Moreno, J. C. Lindon: An integrated molecular and immunological approach towards a meningococcal group B vaccine. Vaccine 5: 11–26 (1987).

    Google Scholar 

  27. A. K. Lehmann, A. Halstensen, A. Naess, S. E. Vollset, H. Sjursen, G. Bjune: Immunization against serogroup B meningococci. Acta Path. Microbiol. Immunol. Scand. 99: 769–772 (1991).

    Google Scholar 

  28. World Health Organization: Operational targets for EPI diseases. Copenhagen: WHO EUR/ICP/EPI031, pp. 3–4 (1993).

    Google Scholar 

  29. N. W. Preston: Pertussis today. In: A. C. Wardlaw, R. Parton, eds. Pathogenesis and immunity in pertussis. Chichester: Wiley, pp. 1–18 (1988).

    Google Scholar 

  30. J. D. Cherry, P. A. Brunell, G. S. Golden, D. T. Karzon: Report of the Task Force on pertussis and pertussis immunization 1988. Pediatrics 81: 939–984 (1988).

    Google Scholar 

  31. E. Versi: “Gold standard” is an appropriate term. Br. Med. J. 305; 187 (1992).

    Google Scholar 

  32. N. W. Preston: The role of serology in the diagnosis of infection. Garyounis Med. J. 6: 79–84 (1983).

    Google Scholar 

  33. Anonymous: Pertussis - adults, infants, and herds. Lancet 339: 526–527 (1992).

    Google Scholar 

  34. P. Camfleld: Brain damage from pertussis immunization. Am. J. Dis. Child. 146: 327–331 (1992).

    Google Scholar 

  35. C.Bowie: Lessons from the pertussis vaccine court trial. Lancet 335: 397–399 (1990).

    Google Scholar 

  36. J. D. Cherry: ‘Pertussis vaccine encephalopathy’ - it is time to recognize it as the myth that it is. JAMA 263: 1679–1680 (1990).

    Google Scholar 

  37. K. R. Wentz, E. K. Marcuse: Diphtheria-tetanus-pertussis vaccine and serious neurologic illness. Pediatrics 87: 287–297 (1991).

    Google Scholar 

  38. N. W. Preston: Type-specific immunity against whooping cough. Br. Med. J. 11: 724–726 (1963).

    Article  Google Scholar 

  39. E. Miller, J. E. Vurdien, J. M. White: The epidemiology of pertussis in England and Wales. Communicable Disease Report 2: R152–R154

    Google Scholar 

  40. N. W. Preston, E. J. Carter: Serotype specificity of vaccine-induced immunity to pertussis. Communicable Disease Report 2: R155–R156 (1992).

    Google Scholar 

  41. R. D. Shahin, M.J. Brennan, Z. M. Li, B. D. Meade, C.R. Manclark: Characterization of the protective capacity and immunogenicity of the 69-KD outer membrane protein of Bordetella pertussis. J. Exp. Med. 777: 63–73 (1990).

    Article  Google Scholar 

  42. J. H. Fredriksen, L. O. Froholm, U. Kjennerud: The specificity of antisera against Bordetella pertussis examined by bacterial agglutination. Acta Path. Microbiol. Immunol. Scand. 95: 363–369 (1987).

    Google Scholar 

  43. Ad hoc group for the study of pertussis vaccines: Placebo-controlled trial of two acellular pertussis vaccines in Sweden. Lancet i: 955–960 (1988).

    Google Scholar 

  44. A. C. Blaskett, J. C. Cox: Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines. Epidem. Infect. 100: 335–344 (1988).

    Article  Google Scholar 

  45. N. W. Preston: Essential immunogens in human pertussis - the role of fimbriae. Develop. Biol. Standard. 61: 137–141 (1985).

    Google Scholar 

  46. A. Giammanco, A. Chiarini, T. Stroffolini, D. de Mattia, M. Chiaramonte, M. E. Moschen: Seroepidemiology of pertussis in Italy. Rev. Infect. Dis. 13: 1216–1220 (1991).

    Google Scholar 

  47. I. Krantz, J. Taranger, B. Trollfors: Estimating incidence of whooping cough overtime. Internat. J. Epidemiol. 18: 959–963 (1989).

    Article  Google Scholar 

  48. E. K. Andersen: Serological studies on H. pertussis, H. parapertussis and H. bronchisepticus. Acta Path. Microbiol. Scand. 33: 202–224 (1953).

    Google Scholar 

  49. N. W. Preston: Assessing the response to pertussis vaccine. Br. Med. J. 303: 1204 (1991).

    Google Scholar 

  50. M. M. Levine, D. R. Nalin, J. P. Craig, D. Hoover, E. J. Bergquist, D. Waterman, et al.: Immunity of cholera in man - relative role of antibacterial versus antitoxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73: 3–9 (1979).

    Article  Google Scholar 

  51. N. W. Preston: Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera - relevance to vaccine immunogenicity. Epidemiol. Infect. 110: 489–497 (1993).

    Article  Google Scholar 

  52. W. H. Mosley, W. E. Woodward, K. M. A. Aziz, A. S. M. M. Rahman, A. K. M. A. Chowdhury, A. Ahmed: The 1968–1969 cholera-vaccine field trial in rural East Pakistan. J. Infect. Dis. 121 Suppl: S 1–S9 (1970).

    Google Scholar 

  53. I. K. Wachsmuth, C. A. Bopp, P. I. Fields, C. Carrillo: Difference between toxigenic Vibrio cholerae 01 from South America and US gulf coast. Lancet 337: 1097–1098 (1991).

    Google Scholar 

  54. S. Kabir: Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae. J. Med. Microbiol. 23: 9–18 (1987).

    Google Scholar 

  55. S. Rahman (ed): Proceedings of the Conference on Experimental Cholera Vaccines, Dacca, Bangladesh, 6–8 April 1981. Dacca: International Centre for Diarrhoeal Disease Research, Special Publication 15, pp. 112–113 (1981).

    Google Scholar 

  56. T. Ramamurthy, S. Garg, R. Sharma, S. K. Bhattacharya, G. B. Nair, T. Shimada, et al.: Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341: 703–704 (1993).

    Article  Google Scholar 

  57. M. J. Albert, A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, et al.: Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh. Lancet 341: 704 (1993).

    Article  Google Scholar 

  58. N. W. Preston: Oral typhoid vaccine Ty21 a. Lancet 338: 1456 (1991).

    Article  Google Scholar 

  59. Anonymous: Typhoid vaccination - weighing the options. Lancet 340: 341–342 (1992).

    Google Scholar 

  60. Anonymous: Typhoid vaccines - which one to choose? Drug Ther. Bull. 31: 9–10 (1993).

    Google Scholar 

  61. I. L. Acharya, C.U. Lowe, R. Thapa, V. L. Gurubacharya, M. B. Shrestha, M. Cadoz, et al.: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N. Engl. J. Med. 317: 1101–1104 (1987).

    Article  Google Scholar 

  62. K. P. Klugman, I. T. Gilbertson, H. J. Koornhof, J. B. Robbins, R. Schneerson, D. Schulz, et al.: Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 11: 1165–1169 (1987).

    Article  Google Scholar 

  63. C. O. Tacket, C. Ferreccio, J. B. Robbins, C-M. Tsai, D. Schulz, M. Cadoz, et al.: Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154: 342–345 (1986).

    Article  Google Scholar 

  64. C. Ferreccio, M. M. Levine, H. Rodriguez, R. Contreras, Chilean Typhoid Committee: Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules. J. Infect. Dis. 159: 766–769 (1989).

    Google Scholar 

  65. N. W. Preston: Typhoid vaccine and laboratory indicators of clinical protection. Lancet 339: 555 (1992).

    Article  Google Scholar 

  66. A. J. Beale: Polio vaccines - time for a change in immunisation policy. Lancet 335: 839–842 (1990).

    Article  Google Scholar 

  67. D.. Murdin, J. Thipphawong: Poliovirus vaccination schedules and reversion to virulence. J. Infect. Dis. 166: 935–936 (1992).

    Article  Google Scholar 

  68. P. W. Kelley, B. P. Petruccelli, P. Stehr-Green, R. L. Erickson, C. J. Mason: The susceptibility of young adult Americans to vaccine-preventable infections. JAMA 266: 2724–2729 (1991).

    Article  Google Scholar 

  69. P. W. Kok, J. Leeuwenburg, P. Tukei, A. L. van Wezel, J. G. Kapsenberg, G. van Steenis, et al.: Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull. Wld. Hlth. Org. 70: 93–103 (1992).

    Google Scholar 

  70. P. Hatton: The use of the screening technique as a method of rapidly estimating vaccine efficacy. Publ. Hlth. 104:21–25 (1990).

    Google Scholar 

  71. C. M. Roberts: The short-term effects of a measles vaccination programme on a rural Nigerian community. J. Trop. Pediatr. 30: 184–188 (1984).

    Google Scholar 

  72. N. W. Preston: Measles control in young infants. Lancet 341: 688–689 (1993).

    Article  Google Scholar 

  73. O. Lindqvist, A. Mark, O. Strannegard: Antibody responses following immunization with combined measles-mumps-rubella (MMR) vaccine of 12-month-old-infants in Kuwait. J. Kuwait.Med. Assoc. 21: 92–96 (1987).

    Google Scholar 

  74. D. Schoub, S. Johnson, J. M. McAnerney, L. A. Wagstaff, W. Matsie, S. G. Reinach, et al.: Measles mumps and rubella immunization at nine months in a developing country. Pediatr. Infect. Dis. J. 9: 263–267 (1990).

    Article  Google Scholar 

  75. M. D. Murphy, P. A. Brunell, A. W. Lievens, Z. M. Shehab: Effect of early immunization on antibody response to reimunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics 74: 90–93 (1984).

    Google Scholar 

  76. R. Berger, M. Just, R. Glück, M. Grassi, A. Wegmann: Measles vaccination in early infancy. Lancet 335: 540 (1990).

    Article  Google Scholar 

  77. World Health Organization EPI: Measles immunisation before the age of nine months? Lancet ii: 1356–1357 (1988).

    Google Scholar 

  78. S. Portoian-Shuhaiber: Mumps and rubella, or measles, mumps and rubella vaccination in children. J. Kuwait Med. Assoc. 21: 136–137 (1987).

    Google Scholar 

  79. K. M. Citron: BCG vaccination against tuberculosis - international perspectives. Br. Med. J. 306: 222–223 (1993).

    Article  Google Scholar 

  80. P. E. M. Fine, L. C. Rodrigues: Mycobacterial diseases. Lancet 335: 1016–1020 (1990).

    Google Scholar 

  81. O. Tidjani, A. Amedome, H. G. ten Dam: The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle 67: 269–281 (1986).

    Article  Google Scholar 

  82. P. d’A. Hart, I. Sutherland, J. Thomas: The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines. Tubercle 48: 201–210 (1967).

    Google Scholar 

  83. Hayward: Re-emergence of tuberculosis. Br. Med. J. 306: 514–515 (1993).

    Google Scholar 

  84. V. M. Cárdenas-Ayala, H. Vilchis-Licón, H. C. Stetler, L. Cabrera-Coello, J. S. Koopman, J. L. Valdespino-Gómez, et al.: Risk factors for the persistence of wild poliovirus transmission in Sinaloa, Mexico, 1984–1986. Pan Am. Hlth. Org. Bull. 22: 227–239 (1988).

    Google Scholar 

  85. J. W. G. Smith, J. A. Lee, W. B. Fletcher, C. A. Morris, D. A. Parker, R. Yetts, et al.: The reponse to oral poliovaccine in persons aged 16–18 years. J. Hyg. Camb. 76: 235–247 (1976).

    Article  Google Scholar 

  86. Suharyono, C. Simanjuntak, N. Witham, N. Punjabi, D. G. Heppner, G. Losonsky, et al.: Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340: 689–694 (1992).

    Google Scholar 

  87. S. J. Cryz, M.M. Levine, G. Losonsky, J. B. Kaper, B. Althaus: Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infect. Immun. 60: 3916–3917 (1992).

    Google Scholar 

  88. J. D. Clemens, B. F. Stanton, J. Chakraborty, D. A. Sack, M. R. Khan, S. Huda, et al.: B subunit-whole cell and whole cell-only oral vaccines against cholera. J. Infect. Dis. 155: 79–85 (1987).

    Article  Google Scholar 

  89. J. D. Clemens, D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, et al.: Field trial of oral cholera vaccines in Bangladesh. Lancet 335: 270–273 (1990).

    Article  Google Scholar 

  90. J. D. Clemens, F. van Loon, D. A. Sack, J. Chakraborty, M. R. Rao, F. Ahmed, et al.: Field trial of oral cholera vaccines in Bangladesh - serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J. Infect. Dis. 163: 1235–1242 (1991).

    Article  Google Scholar 

  91. Sesardic, M. J. Corbel: Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin. Lancet 340: 737–738 (1992).

    Article  Google Scholar 

  92. S. Isomura: Efficacy and safety of acellular pertussis vaccine in Aichi Prefecture, Japan. Pediatr. Infect. Dis. J. 7: 258–262 (1988).

    Article  Google Scholar 

  93. K. M. Edwards, R. B. Bradley, M. D. Decker, P. S. Palmer, J. van Savage, J. C. Taylor, et al.: Evaluation of a new highly purified pertussis vaccine in infants and children. J. Infect. Dis. 160: 832–837 (1989).

    Article  Google Scholar 

  94. A. C. Wardlaw: Multiple discontinuity as a remarkable feature of the development of acellular pertussis vaccines. Vaccine 10: 643–651 (1992).

    Article  Google Scholar 

  95. D. Shapiro: Pertussis vaccines - seeking a better mousetrap. JAMA 267: 2788–2790 (1992).

    Google Scholar 

  96. N. W. Preston: Pertussis vaccine. Lancet 335:1162 (1990). V. I. Levenson, T. P. Egorova, Z. P. Belkin, V. G. Fedosova, J. L. Subbo- tina, E. Z. Rukhadze: Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect. Immun. 59: 3610–3618 (1991).

    Google Scholar 

  97. V. I. Levenson, T. P. Egorova, Z. P. Belkin, V. G. Fedosova, J. L. Subbo- tina, E. Z. Rukhadze,: Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect. Immun. 59: 3610–3618 (1991).

    Google Scholar 

  98. N. W. Preston: Antigens that modern vaccines must contain. Lancet 336: 756–757 (1990).

    Article  Google Scholar 

  99. Brown: From Jenner to genes - the new vaccines. Lancet 335: 587–590 (1990).

    Article  Google Scholar 

  100. J. C. Kelsey: The AP Syndrome. Br. Med. J. IV: 104, 360 (1973).

    Google Scholar 

  101. A. Hanrahan, J. Waters: Adverse local reactions to fourth and fifth doses of DPT vaccine - Alberta. Canada Diseases Weekly Report 14: 45–47

    Google Scholar 

  102. D. W. Scheifele, W. Meekison, M.Grace, L. Barreto, A. O. Carter, L. Mitchell: Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. Canad. Med. Assoc. J. 145: 641–647 (1991).

    Google Scholar 

  103. P. L. Verschoor, J. T. Wilschut, G. A. de Jonge, P. J. Kostense: Frequent symptoms after DTPP vaccinations. Arch. Dis. Child. 66: 1408–1412 (1991).

    Google Scholar 

  104. M. M. Ipp, R. Gold, S. Greenberg, M. Goldbach, B. B. Kupfert, D. D. Lloyd, et al.: Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. Pediatr. Infect. Dis. J. 6: 721–725 (1987).

    Article  Google Scholar 

  105. Anonymous: Prophylactic paracetamol with childhood immunisation? Drug Ther. Bull. 28: 73–74 (1990).

    Google Scholar 

  106. L. J. Baraff, C. R. Manclark, J. D. Cherry, P. Christenson, S. M. Marcy: Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr. Infect. Dis. J. 8: 502–507

    Google Scholar 

  107. C. M. Morgan, D. A. Blumberg, J. D. Cherry, K. S. Reisinger, M. M. Blatter, J. L. Blumer, et al.: Comparison of acellular and whole-cell pertussis- component DTP vaccines. Am. J. Dis. Child. 144: 41–45 (1990).

    Google Scholar 

  108. S. A. Plotkin, E. A. Mortimer: Vaccines. London: Saunders, pp. 612–621 (1988).

    Google Scholar 

  109. M. H. Smith: National Childhood Vaccine Injury Compensation Act. Pediatrics 82: 264–269 (1988).

    Google Scholar 

  110. T. Nakayama, T. Urano, M. Osano, M. Nakagawa, N. Maehara, K. Sasaki, et al.: Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-production and antibody response. Microbiol. Immunol. 34: 497–508 (1990).

    Google Scholar 

  111. A. Colville, S. Pugh: Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 340: 786 (1992).

    Article  Google Scholar 

  112. T. Forsey, M. L. Bentley, P. D. Minor, N. Begg: Mumps vaccines and meningitis. Lancet 340: 980 (1992).

    Article  Google Scholar 

  113. J. P. Grant: Getting vaccination to the people. Wld. Hlth. Forum 7: 184 (1986).

    Google Scholar 

  114. World Health Organization: Expanded Programme on Immunization - programme acceleration. Wkly Epidemiol. Record 62: 173–175 (1987).

    Google Scholar 

  115. T. Thomas: Why child vaccines may be a shot in the dark. The Independent newspaper, No. 1968, p. 12(1993).

    Google Scholar 

  116. N. W. Preston: Accelerated immunisation with diphtheria-tetanus-pertus- sis vaccine. Br. Med. J. 303: 248 (1991).

    Article  Google Scholar 

  117. L. J. Baraff, R. D. Leake, D. G. Burstyn, T. Payne, C. L. Cody, C. R. Manclark, et al.: Immunologic response to early and routine DTP immunization in infants. Pediatrics 73: 11–42 (1984).

    Google Scholar 

  118. R. Booy, S. J. M. Aitken, S. Taylor, G. Tudor-Williams, J. A. MacFarlane, E.R. Moxon: Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 339: 507–510 (1992).

    Google Scholar 

  119. J. van Savage, M. D. Decker, K. M. Edwards, S. H. Sell, D. T. Karzon: Natural history of pertussis antibody in the infant and effect on vaccine response. J. Infect. Dis. 161: 487–492 (1990).

    Article  Google Scholar 

  120. N. W. Preston: Diphtheria, pertussis, and tetanus vaccination. Lancet 339: 1356 (1992).

    Google Scholar 

  121. D. Alford, J. Kelly, T. J. Halpin, L. Nickey, R. Crider, J. Arrandondo, et al.: Retrospective assessment of vaccination coverage among school-aged children. MMWR 41: 103–107 (1992).

    Google Scholar 

  122. S. S. Long, A. Deforest, D. G. Smith, C. Lazaro, S. G. F. Wassilak: Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics 85: 294–302 (1990).

    Google Scholar 

  123. D. De-xiang, H. Xi-min, L. Wan-jun, L. Jin-shen, J. Yu-cai, T. Shun-ge, et al.: Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull. Wld. Hlth. Org. 64: 853–860 (1986).

    Google Scholar 

  124. L. Y. Weckx, B. J. Schmidt, A. A. Herrmann, C. H. Miyasaki, N. F. Novo: Early immunization of neonates with trivalent oral poliovirus vaccine. Bull. Wld. Hlth. Org. 70: 85 - 91 (1992).

    Google Scholar 

  125. G. Hess, V. Hingst, J. Cseke, H. L. Bock, R. Clemens: Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur. J. Clin. Microbiol. Infect. Dis. 11: 334–340 (1992).

    Article  Google Scholar 

  126. P. Poore, F. Cutts, J. Seaman: Universal Childhood Immunisation - is it sustainable Lancet 341: 58 (1993).

    Article  Google Scholar 

  127. J. Beale: Obituary - Albert Sabin. Lancet 341: 685 (1993).

    Google Scholar 

  128. R. D. Ebong: An evaluation of immunization coverage of Nigerian army depot. J. Roy. Soc. Hlth. February: 3–6 (1992).

    Google Scholar 

  129. T. Lewis, L. M. Osborn, K. Lewis, J. Brockert, J. Jacobsen, J. D. Cherry: Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates. Am. J. Dis. Child. 142: 283–286 (1988).

    Google Scholar 

  130. P. Stehr-Green, C. Briasco, M. Baker, P. Trotter: How well are we protecting our children? - an immunisation coverage survey in Hawke’s Bay. NZ. Med. J. 105: 277–279 (1992).

    Google Scholar 

  131. P. Bennett, C. Smith: Parents attitudinal and social influences on childhood vaccination. Hlth. Education Res. 7: 341–348 (1992).

    Article  Google Scholar 

  132. D. J. Riley, M. Z. Mughal, J. Roland: Immunisation state of young children admitted to hospital and effectiveness of a ward based opportunistic immunisation policy. Br. Med. J. 302: 31–33 (1991).

    Article  Google Scholar 

  133. M. R. Z. Capeding, J. A. Lazaro, Y. Y. Kaneko: Pre-discharge immunization among hospitalized Filipino children. Pediatr. Infect. Dis. J. 9: 570–573 (1990).

    Article  Google Scholar 

  134. L. D. Ritchie, A. F. Bisset, D. Russell, V. Leslie, I. Thomson: Primary and preschool immunisation in Grampian - progress and the 1990 contract. Br. Med. J. 304: 816–819 (1992).

    Article  Google Scholar 

  135. J. D. Cherry: The pertussis epidemic in Oklahoma - a warning for the future. Am. J. Dis. Child. 140: 417–418 (1986).

    Google Scholar 

  136. J. B. Robbins, J. C. Hill, J. C. Sadoff (eds): Bacterial vaccines. In: L. Weinstein, B. N. Fields, Seminars in Infectious Disease, vol. I V. New York: Thieme-Stratton (1982).

    Google Scholar 

  137. G. C. Schild, P. D. Minor: Human immunodeficiency virus and AIDS - challenges and progress. Lancet 335: 1081–1084 (1990).

    Article  Google Scholar 

  138. N. W. Preston: Self-control crucial to health promotion. Hospital Doctor C 72(4): 14(1992).

    Google Scholar 

  139. World Health Organization: “AIDS: a community commitment” is the theme of World AIDS Day 1992. Wld. Hlth. Forum 13:270 (1992).

    Google Scholar 

  140. World Health Organization: New AIDS strategy. Wld. Hlth. Forum 13: 92 (1992).

    Google Scholar 

  141. Anonymous: Switzerland (WHO) - resignation of Dr Jonathan Mann. Lancet 335: 716 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University Medical School, Manchester, M 13 9 PT, UK

    Noel W. Preston

Authors
  1. Noel W. Preston
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Basel, Switzerland

    Ernst Jucker

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Birkhäuser Verlag Basel

About this chapter

Cite this chapter

Preston, N.W. (1993). Eradication by vaccination: the memorial to smallpox could be surrounded by others. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 41. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7150-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7150-1_6

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7152-5

  • Online ISBN: 978-3-0348-7150-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation